COST PER RESPONDER TO USTEKINUMAB BASED ON THE FIRSTLINE ANTI-TNFαTREATMENT IN MODERATE-SEVERE PSORIASIS

COST PER RESPONDER TO USTEKINUMAB BASED ON THE FIRSTLINE ANTI-TNFαTREATMENT IN MODERATE-SEVERE PSORIASIS